YDES
YD Bio Ltd
NASDAQ: YDES · HEALTHCARE · BIOTECHNOLOGY
$7.42
-2.50% today
Updated 2026-09-30
Market cap
$539.03M
P/E ratio
0.00
P/S ratio
434.94x
EPS (TTM)
$0.00
Dividend yield
—
52W range
$2 – $22
Volume
0.3M
YD Bio Ltd (YDES) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
0 of 8
Last 8 quarters
Avg EPS surprise
—
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
-116.0%
Most recent quarter
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-06-30 | — | $-0.65 | — | — | — |
| 2025-03-31 | — | $-1.10 | — | — | — |
| 2024-12-31 | — | $0.10 | — | — | — |
| 2024-09-30 | — | $-0.16 | — | — | — |
| 2024-06-30 | — | $4.05 | — | — | — |
| 2024-03-31 | — | $-5.12 | — | — | — |
| 2023-12-31 | — | $0.16 | — | — | — |
| 2023-09-30 | — | $-0.25 | — | — | — |
| 2023-06-30 | — | $-0.35 | — | — | — |
| 2023-03-31 | — | $-0.14 | — | — | — |
| 2022-12-31 | — | $-0.22 | — | — | — |
| 2022-09-30 | — | $0.20 | — | — | — |
Frequently asked questions
Has YD Bio Ltd beaten earnings estimates?
YD Bio Ltd has beaten Wall Street EPS estimates in 0 of its last 8 quarterly reports. A consistent beat record suggests management guides conservatively and the business has predictable momentum, which tends to support the stock through earnings season.